Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (marketed as HALAVEN®) will be presented during the 42nd San Antonio...

Join us at SOLAR 20/20, a global solar event at the right place and at the right time. The events of the moment -- international pronouncements by international bodies of scientists on climate...

Senior Helpers®, the nation's premier provider of personalized in-home senior care, today announced it will host an educational session on caregiving techniques for dementia patients on January...

Converging Supply Chain Markets and Accelerated SaaS Adoption Drive Record-Breaking Momentum MONTREAL, Dec. 10, 2019 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing the addition of DARZALEX® (daratumumab) to carfilzomib (Kyprolis®) and...